Research: Clinical Antipsychotic Trials of
Intervention Effectiveness (CATIE)
Clinical Antipsychotic Trials of Intervention Effectiveness, or CATIE,
is a landmark comparative research of four newer atypical antipsychotic
medications and one older, conventional one. The largest study of its kind,
CATIE reinforces what mental health consumers have said for years:
one size does not fit
all.
On March 1, 2007, the latest results (Phase 1B) of the Clinical Trials
of Intervention Effectiveness (CATIE) Study were released in the
American Journal of Psychiatry.
Phase 1 and Phase 2 results were previously released in September 2005 in the
New England Journal of
Medicine and on April 1, 2006 in
the American Journal of
Psychiatry respectively.
1]
CATIE is the first comprehensive effectiveness study to compare older
and newer generation antipsychotic medications. One more phase of this study is
expected. To ensure that media, clinician and policymaker interpretation of
these and future study results is not misrepresented; NMHA has updated its
existing materials / resources about the study.
|
